Vicodin vex: DEA tightens restrictions on hydrocodone combos

From NeurologyWire

On Friday the US Drug Enforcement Administration (DEA) will move hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II.Pure hydrocodone drugs have been listed as Schedule II drugs since the creation of the list in 1971. But hydrocodone-combination products (HCPs)those made with specified amounts of other ther...

Login to read story

Thursday, August 28, 2014

Show last days of articles

Civitas raises $55M for Phase III Parkinson's study, doesn't...

From NeurologyWire

Civitas Therapeutics announced they have raised $55 million through Series C financing, to be used toward the upcoming Phase III clinical trials for t...Full story

Wednesday, August 27, 2014

Lack of key protein linked to dementia

From NeurologyWire

Scientists at the University of Warwick have provided the first evidence that the lack of a naturally occurring protein is linked to early signs of de...Full story

Tuesday, August 26, 2014

Wii Balance Board induces changes in MS patients

From NeurologyWire

A balance board accessory for a popular video game console can help people with multiple sclerosis (MS) reduce their risk of accidental falls, accordi...Full story

FDA reiterates that, no, dietary supplements cannot treat a ...

From NeurologyWire

When it's back-to-school time, it's also back to football, soccer and other sports that may cause a head injury. That makes it prime time to exploit t...Full story

Friday, August 22, 2014

HHS sets Oct. 1 deadline for transition to ICD-10

From NeurologyWire

The U.S. Department of Health and Human Services (HHS) set Oct. 1, 2015 as the new compliance date for health care providers, health plans, and health...Full story

Thursday, August 21, 2014

Rob Schneider's PD Twitter Rant Off Base

From NeurologyWire

Comedian Rob Schneider went on a Twitter rant blaming Parkinson's drugs for Robin Williams' death, and he isn't backtracking. Williams' widow said he ...Full story

Wednesday, August 20, 2014

Drug used for dementia symptoms carries kidney risks

From NeurologyWire

Atypical antipsychotic drug use is associated with an increased risk for acute kidney injury (AKI), according to a new study in the Annals of Internal...Full story

Cholesterol drug cuts heart and stroke risks by 30 percent i...

From NeurologyWire

The cholesterol-lowering drug fenofibrate cuts cardiovascular disease risks by 30 per cent in women with type-2 diabetes, a new University of Sydney s...Full story

Monday, August 18, 2014

Epilepsy drug Fycompa rebuffed, again, in Germany

From NeurologyWire

The German Institute for Quality and Efficiency in Healthcare (IQWiG) has said that epilepsy drug Fycompa (perampanel) from Japanese drug major Eisai ...Full story

Surgeons use new device to treat cluster headaches

From NeurologyWire

For those suffering excruciating pain from cluster headaches, relief may soon be available from an investigational device being studied in a national ...Full story

Friday, August 15, 2014

AMA asks CMS to Delay Publication of the Sunshine Act Databa...

From NeurologyWire

The American Medical Association (AMA) is calling on the Centers for Medicare and Medicaid Services (CMS) to expand the timeframe for registering and ...Full story

Thursday, August 14, 2014

AHA Sticks to Its Guns on Sodium

From NeurologyWire

Excessive sodium consumption is having a dire health impact on people around the world, the American Heart Association maintains, after Thursday saw t...Full story

FDA approves new type of sleep drug, Belsomra

From NeurologyWire

The U.S. Food and Drug Administration has approved Belsomra (suvorexant) tablets for use as needed to treat difficulty in falling and staying asleep.B...Full story

Wednesday, August 13, 2014

Decline in daily functioning related to decreased brain acti...

From NeurologyWire

Decline in daily functioning associated with Alzheimer's disease is related to alterations in activity in certain regions of the brain, according to a...Full story

Reduction of tau protein improves symptoms in model of sever...

From NeurologyWire

Researchers at the Gladstone Institutes have shown that reducing brain levels of the protein tau effectively blocks the development of disease in a mo...Full story